Clover Health publishes supplemental Q&A on Q2 2026 results and outlook

CLOVER HEALTH INVESTMENTS, CORP. /DE

Clover Health published a supplemental shareholder Q&A on August 20, 2026, addressing Q2 2026 results and 2026 outlook.
The Q&A document, furnished as Exhibit 99.1, includes only an introductory letter from CEO Andrew Toy; no Q&A content is provided in the excerpt.
No specific financial figures, guidance changes, or operational updates are disclosed in the available text.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.